Revisiting the Value of Routine Immunohistochemical Markers for Predicting Pathologic Response and Prognosis in Estrogen Receptor-Strong Positive and HER2 Negative Breast Cancer

First Author / 第一作者

Su Min Lee

Institution / 單位

Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Audio / 音訊檔

Author Group / 作者群

N/A

Author Group Institution/ 作者群單位

Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Neoadjuvant chemotherapy, ER-positive, HER2-negative, breast cancer, pathologic complete response, immunohistochemistry, prediction model, basal-like markers, Ki-67, PR negative

Back to list